Interfering with protein-protein interactions: potential for cancer therapy.

Abstract excerpt

Genotype-specific cancer therapy promises to engender the era of personalised medicines in which rapid identification of tumour specific gene mutations coupled to rapid methods for efficacious drug identification will be applied. Aberrant signal transduction via protein-protein interactions is generally difficult to target with small molecules. However, macromolecules (macrodrugs) can be developed that interfere...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Macromolecular Substances
• Share to Models, Biological
• Share to Drug Design